Heidi in the news

Heidi II's AI agents extract patient data from Australian Practice Management Systems, likely breaching vendor terms and conditions, creating a market disruption and legal uncertainty.

Heidi II, an AI clinical workflow layer, launched with features like pre-charted patient summaries and AI agents to handle administrative tasks during consultations.

Heidi launched Heidi II, an AI clinical workflow layer, demonstrating its ability to integrate with existing EMRs via RPA and HealthLink, posing a challenge to incumbent medical software providers.

Heidi Health's new AI platform, Heidi II, introduces agents capable of navigating clinical software and performing administrative tasks, even without direct EMR integration, by taking control of the keyboard and mouse.

Heidi Health is introducing AI administrative agents to automate tasks for doctors, enabling more patient-focused care.

Heidi II automates administrative tasks around patient visits with AI agents, improving clinical efficiency and patient care.

Heidi II, an AI care partner, has launched a new product that expands its capabilities from documenting clinical visits to automating post-consultation administrative tasks like referrals and forms.

Heidi Health's new platform, Heidi II, uses AI agents to automate clinical administrative tasks like chart preparation, referrals, and appointment management.

Heidi secured $340 million in funding to expand its AI healthcare solutions and presence across the Asia-Pacific region.

Heidi, an AI-powered healthcare platform, raised $140 million in Series C funding and an additional $335 million, valuing the company at $1.26 billion to expand its AI capabilities for medical professionals.

Heidi Health reached unicorn status with a $477 million funding round, valuing it over $1 billion, to expand its AI Care Partner technology for clinicians globally.

Heidi, an Australian AI company, secured $480 million in funding to evolve its AI transcription tool into an agentic care partner, aiming to suggest clinical decisions and achieve unicorn status amidst privacy and accuracy concerns.

Heidi, an AI care partner medical company, secured US$340 million in funding, reaching a US$900 million valuation and plans to expand into Asia and the Middle East.

Heidi secured $480 million in funding and credit to accelerate global AI Care Partner adoption, facing intense competition and pressure to meet performance benchmarks for the debt facility.

Heidi, a Melbourne-based AI scribe, secured USD340 million in new financing, reaching a USD900 million valuation, and is expanding its global AI healthcare services.

Heidi, an AI clinical notes taker, secured $340 million in new funding, reaching a $1.26 billion valuation, to expand its AI agent development and global sales.

Heidi, an AI care partner, secured US$340 million in funding, achieving a US$900 million valuation, to expand its global AI capabilities for health systems.

Heidi, an AI-powered healthcare platform, secured $475 million in funding, valuing the company at $1.26 billion, to expand its AI capabilities for medical professionals.

Heidi Health, an AI care partner medical company, has achieved a $1 billion valuation and $50 million in annual revenue, with a goal to partner AI with every doctor worldwide.

Heidi, an AI startup, secured $100 million in a Series C funding round, doubling its valuation to $900 million.